Purchases and Sales Made in Q1 2024 in Lexaria Bioscience Corp. (LEXX)
This table provides information about the institutional ownership of Lexaria Bioscience Corp. (LEXX) during Q1 2024. The information is specifically focused on institutions that hold shares of Lexaria Bioscience Corp..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2024
Q1 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
45.7K+ 85.36% |
$59K - $286K
|
99.3K
$218K
|
|
|
Apr 22, 2024
Q1 2024
|
Raymond James Financial Services Advisors, Inc.
St. Petersburg, FL |
BUY
|
- |
39.6KNew |
$51K - $247K
|
39.6K
$86.6K
|
|
|
May 15, 2024
Q1 2024
|
State Street Corp
Boston, MA |
BUY
|
- |
39.3KNew |
$50.7K - $246K
|
39.3K
$86.1K
|
|
|
May 10, 2024
Q1 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
38.9K+ 84.16% |
$50.2K - $243K
|
85.2K
$186K
|
|
|
May 15, 2024
Q1 2024
|
Adar1 Capital Management, LLC
Austin, TX |
BUY
|
- |
25K+ 1537.52% |
$32.3K - $156K
|
26.6K
$58.3K
|
|
|
Apr 09, 2024
Q1 2024
|
Welch Group, LLC
|
BUY
|
- |
24KNew |
$31K - $150K
|
24K
$52.6K
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
23.4KNew |
$30.1K - $146K
|
23.4K
$51.1K
|
|
|
May 14, 2024
Q1 2024
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
18.4KNew |
$23.7K - $115K
|
18.4K
$40.3K
|
|
|
Apr 15, 2024
Q1 2024
|
Wealth Enhancement Advisory Services, LLC
|
BUY
|
- |
10.3KNew |
$13.3K - $64.5K
|
10.3K
$22.6K
|
|
|
May 13, 2024
Q1 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
10.3KNew |
$13.3K - $64.2K
|
10.3K
$22.5K
|
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
6.89K+ 1748.48% |
$8.89K - $43.1K
|
7.28K
$15.9K
|
|
|
Apr 22, 2024
Q1 2024
|
Oakworth Capital, Inc.
|
BUY
|
- |
5KNew |
$6.45K - $31.3K
|
5K
$11K
|
|
|
May 10, 2024
Q1 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
1.74K+ 386.67% |
$2.24K - $10.9K
|
2.19K
$4.8K
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
BUY
|
- |
1.51KNew |
$1.95K - $9.43K
|
1.51K
$3.3K
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
372+ 1.62% |
$480 - $2.33K
|
23.4K
$51.1K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
BUY
|
- |
372+ 1.62% |
$480 - $2.33K
|
23.4K
$51.1K
|
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
237New |
$306 - $1.48K
|
237
$519
|
|
|
May 10, 2024
Q1 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
11+ 1.04% |
$14.2 - $68.8
|
1.07K
$2.35K
|
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 15, 2024
Q1 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-3.11K- 53.49% |
$4.01K - $19.4K
|
2.7K
$5.92K
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-13.7K- 46.36% |
$17.7K - $85.7K
|
15.9K
$34.7K
|
|
|
May 15, 2024
Q1 2024
|
Invenomic Capital Management LP
Boston, MA |
SELL
|
- |
-259K- 35.34% |
$334K - $1.62M
|
473K
$1.04M
|